BARACLUDE 0.05 mg/ml, oral solution bottle, 210 ml
Active ingredients: Entecavir, Entecavir hydrate
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 210 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BARACLUDE 0,05 mg/ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 210 ml avec fermeture de sécurité enfant avec cuillère-mesure polypropylène
- Marketing authorisation holder
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Mar 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62066808CIP73762928CIP133400937629287Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ENTÉCAVIR MONOHYDRATÉsolution | — | SA |
| ENTÉCAVIRsolution | 0,05 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.